AUTOACTIVATION OF COLON CANCER CELLS--TGF INTRACELL
AUTOACTIVATION OF COLON CANCER CELLS--TGF INTRACELL
批准号:
2096166
负责人:
MICHAEL G BRATTAIN
金额:
$18.17万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-08-01 至 1998-05-31
关键词:
antisense nucleic acid autocrine biological signal transduction cancer registry /resource carcinoma cell bank /registry cell differentiation cell growth regulation colon neoplasms flow cytometry gene expression growth factor receptors immunocytochemistry neoplasm /cancer genetics nucleic acid sequence platelet derived growth factor transfection transforming growth factors
中文摘要
在支持该项目的前一阶段,我们描述了
细胞内TGF α自分泌环。 具有细胞内
TGF α表达大量的细胞内前体TGF α,
相对于其他细胞,其处理速度异常缓慢。
因此,它们继续表达高细胞内水平的
非分裂、非循环状态下的TGF α,如静止状态
是由营养和生长因子缺乏引起的。 细胞内
自分泌活动的位置导致无法进入
这些细胞中的TGF α自分泌活性对TGF α中和
抗体和EGFtau阻断抗体。 然而,组成型TGF α
反义载体表达导致获得EGF依赖性。
反义转染的细胞不表达高水平的细胞内
TGF α表达和转录降低,
分裂国家。 它们类似于分化良好的生长因子
依赖性结肠癌细胞,因为这些细胞还需要
外源EGF用于克隆生长和从静止释放。 他们还
显示低水平的细胞内TGF α和降低的
非分裂状态下的TGF α。
这些结果使我们假设TGF α作为一种
自分泌因子,以帮助克隆生长或逃逸的启动
从静止期结肠癌细胞和它的内部位置,
一些细胞由于不适当地调节细胞的生长而提供生长调节优势,
在非周期性生长状态如静止期高表达。 是
进一步假设该因子不具有刺激功能
为指数增长的细胞。 此外,最近还发现,
其他EGF相关肽,双调蛋白(AR)和cripto(CR),
也是结肠癌中的自分泌调节因子。 我们假设
这些因素将与TGF α在控制
功能的表达和时间控制。 这些假设将是
测试人:
1. 确定指数和非指数型中TGF α的自分泌功能
划分增长监管国家。
2. 确定TGF α,
AR和CR。
3. 测定AR的自分泌功能。
4. 测定CR的自分泌功能。
英文摘要
In the previous period of support for this project we characterized an
intracellular TGFalpha autocrine loop. Cells with an intracellular
TGFalpha express high amounts of intracellular precursor TGFalpha which
has an abnormally slow rate of processing relative to other cells.
Consequently, they continue to express high intracellular levels of
TGFalpha in non-dividing, non-cycling states such as the quiescent state
generated by nutrient and growth factor deprivation. The intracellular
location of the autocrine activity results in the inaccessibility of
TGFalpha autocrine activity in these cells to TGFalpha neutralizing
antibodies and EGFtau blocking antibodies. However, constitutive TGFalpha
anti-sense vector expression results in the acquisition of EGF dependency.
Anti-sense transfected cells do not express high levels of intracellular
TGFalpha and show decreased TGFalpha expression and transcription in non-
dividing states. They are similar to well-differentiated, growth factor
dependent colon carcinoma cells in this regard as these cells also require
exogenous EGF for clonal growth and release from quiescence. They also
show low levels of intracellular TGFalpha and reduced expression of
TGFalpha in non-dividing states.
These results have led us to hypothesize that TGFalpha acts as an
autocrine factor to aid in the initiation of clonal growth or the escape
from quiescence in colon carcinoma cells and that its internal location in
some cells provides a growth regulatory advantage due to inappropriately
high expression in non-cycling growth states such as quiescence. It is
further hypothesized that the factor does not have a stimulatory function
for exponentially growing cells. Moreover, it has recently been found
that other EGF related peptides, amphiregulin (AR), and cripto (CR), are
also autocrine regulatory factors in colon cancer. We hypothesize that
these factors will interrelate with TGFalpha in terms of control of
expression and temporal control of function. These hypothesizes will be
tested by:
1. Determining the autocrine function of TGFalpha in exponential and non-
dividing growth regulatory states.
2. Determine interrelationship of control of expression among TGFalpha,
AR and CR.
3. Determine the autocrine function of AR.
4. Determine the autocrine function of CR.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Career Development Program
-
批准号:8328173
-
项目类别:
-
资助金额:$10.35万
-
财政年份:2011
-
负责人:MICHAEL G BRATTAIN
-
依托单位:
Developmental Research Program
-
批准号:8328172
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2011
-
负责人:MICHAEL G BRATTAIN
-
依托单位:
Developmental Research Program
-
批准号:7507424
-
项目类别:
-
资助金额:$4.94万
-
财政年份:2008
-
负责人:MICHAEL G BRATTAIN
-
依托单位:
Novel Strategies for Pancreatic Cancer Treatment
-
批准号:8738890
-
项目类别:
-
资助金额:$36.41万
-
财政年份:2008
-
负责人:MICHAEL G BRATTAIN
-
依托单位:
Career Development Program
-
批准号:7507425
-
项目类别:
-
资助金额:$8.01万
-
财政年份:2008
-
负责人:MICHAEL G BRATTAIN
-
依托单位:
AUTOCRINE TGF BETA AND CELL DEATH
-
批准号:8101847
-
项目类别:
-
资助金额:$24.14万
-
财政年份:1997
-
负责人:MICHAEL G BRATTAIN
-
依托单位:
AUTOCRINE TGF BETA AND CELL DEATH
-
批准号:7667447
-
项目类别:
-
资助金额:$24.89万
-
财政年份:1997
-
负责人:MICHAEL G BRATTAIN
-
依托单位:
AUTOCRINE TGF B AND BREAST CANCER CELL GROWTH
-
批准号:6173215
-
项目类别:
-
资助金额:$18.21万
-
财政年份:1997
-
负责人:MICHAEL G BRATTAIN
-
依托单位:
Autocrine TGFBeta and Breast Cancer Cell Growth
-
批准号:6794648
-
项目类别:
-
资助金额:$28.02万
-
财政年份:1997
-
负责人:MICHAEL G BRATTAIN
-
依托单位:
Autocrine TGFBeta and Breast Cancer Cell Growth
-
批准号:6619638
-
项目类别:
-
资助金额:$27.69万
-
财政年份:1997
-
负责人:MICHAEL G BRATTAIN
-
依托单位:
AUTOCRINE TGF BETA AND CELL DEATH
-
批准号:7323806
-
项目类别:
-
资助金额:$24.89万
-
财政年份:1997
-
负责人:MICHAEL G BRATTAIN
-
依托单位:
Autocrine TGFBeta and Breast Cancer Cell Growth
-
批准号:6335972
-
项目类别:
-
资助金额:$27.05万
-
财政年份:1997
-
负责人:MICHAEL G BRATTAIN
-
依托单位:
Autocrine TGFBeta and Breast Cancer Cell Growth
-
批准号:6934603
-
项目类别:
-
资助金额:$28.37万
-
财政年份:1997
-
负责人:MICHAEL G BRATTAIN
-
依托单位:
AUTOCRINE TGF BETA AND CELL DEATH
-
批准号:7899945
-
项目类别:
-
资助金额:$24.89万
-
财政年份:1997
-
负责人:MICHAEL G BRATTAIN
-
依托单位:
AUTOCRINE TGF BETA AND CELL DEATH
-
批准号:7496481
-
项目类别:
-
资助金额:$24.89万
-
财政年份:1997
-
负责人:MICHAEL G BRATTAIN
-
依托单位:
Autocrine TGFBeta and Breast Cancer Cell Growth
-
批准号:6522374
-
项目类别:
-
资助金额:$27.37万
-
财政年份:1997
-
负责人:MICHAEL G BRATTAIN
-
依托单位:
AUTOCRINE TGF B AND BREAST CANCER CELL GROWTH
-
批准号:2010268
-
项目类别:
-
资助金额:$18.74万
-
财政年份:1997
-
负责人:MICHAEL G BRATTAIN
-
依托单位:
AUTOCRINE TGF B AND BREAST CANCER CELL GROWTH
-
批准号:2683672
-
项目类别:
-
资助金额:$18.42万
-
财政年份:1997
-
负责人:MICHAEL G BRATTAIN
-
依托单位:
AUTOCRINE TGF B AND BREAST CANCER CELL GROWTH
-
批准号:2895687
-
项目类别:
-
资助金额:$17.74万
-
财政年份:1997
-
负责人:MICHAEL G BRATTAIN
-
依托单位:
AUTOCRINE TGF-A-- FUNCTION AND CONTROL IN COLON CANCER
-
批准号:6341933
-
项目类别:
-
资助金额:$4.73万
-
财政年份:1991
-
负责人:MICHAEL G BRATTAIN
-
依托单位:
海外基金